Cartia Xt is a prescription medication formulated as an extended-release tablet containing metoprolol tartrate. It is used clinically to manage high blood pressure and to reduce the workload of the heart in patients with stable angina. The drug belongs to the class of selective beta-1 adrenergic receptor blockers that act on cardiac tissue. By blocking beta-1 receptors the medication diminishes the effects of sympathetic neurotransmitters on the heart. This results in a slower heart rate, reduced myocardial contractility and lower oxygen demand of the cardiac muscle. The controlled-release mechanism provides a gradual increase in drug concentration that is sustained for approximately twenty-four hours. Absorption occurs in the gastrointestinal tract, distribution spans the bloodstream to target tissues, hepatic metabolism converts the compound to inactive metabolites, and renal excretion removes the residues. The overall pharmacological effect is a steady reduction of blood pressure and improved myocardial oxygen supply without abrupt peaks or troughs in plasma levels.

Cartia Xt is a prescription medication used to help prevent serious heart problems in adults. It belongs to a class of drugs called antiplatelet agents that work by reducing the ability of blood platelets to stick together. The active ingredient in Cartia Xt is clopidogrel bisulfate, which is a prodrug that is converted in the liver to its active form. The active form binds to the p2y12 receptor on platelets, blocking the action of adp and thereby inhibiting platelet activation. By decreasing platelet aggregation the drug helps maintain blood flow and lowers the risk of clot formation that can cause heart attack or stroke. After oral administration the drug is absorbed into the bloodstream, reaches peak levels within a few hours and is eliminated mainly through the liver. The overall pharmacological profile of Cartia Xt provides sustained inhibition of platelet function to support long-term cardiovascular protection.

Cartia Xt may cause stomach discomfort in some people. It can increase the risk of bleeding, especially when combined with other blood-thinners. Some users experience ringing in the ears or hearing changes. Headache or dizziness may occur after taking the medication. Rarely, allergic reactions such as rash or swelling can develop. Prolonged use may affect kidney function in susceptible individuals. Long-term aspirin therapy can sometimes lead to gut irritation or ulcer formation.

Common side effects include stomach discomfort and mild nausea. Some users may experience headache or dizziness. Less frequent effects can involve ringing in the ears or blurred vision. Rare but serious reactions may include gastrointestinal bleeding or allergic skin rash. The medication can occasionally cause increased bruising or prolonged bleeding. Patients may notice changes in taste or a metallic sensation in the mouth. Mild fatigue or occasional swelling of the ankles has also been reported. These effects are generally mild and often resolve with continued use.